Group One Trading’s Janux Therapeutics JANX Stock Holding History

Group One Trading’s Portfolio JANX Stock Details JANX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$167K	Buy	12,000 +1,800	+18%	+$24.7K	﹤0.01%	4270
2025 Q4	$141K	Buy	10,200 +8,500	+500%	+$200K	﹤0.01%	4690
2025 Q3	$41.5K	Sell	1,700 -300	-15%	-$7.31K	﹤0.01%	6125
2025 Q2	$46.2K	Sell	2,000 -4,800	-71%	-$126K	﹤0.01%	5643
2025 Q1	$184K	Sell	6,800 -600	-8%	-$22.6K	﹤0.01%	4090
2024 Q4	$396K	Buy	7,400 +3,700	+100%	+$196K	﹤0.01%	3368
2024 Q3	$168K	Buy	3,700 +1,200	+48%	+$52.2K	﹤0.01%	3780
2024 Q2	$105K	Buy	2,500 +1,400	+127%	+$65.7K	﹤0.01%	3928
2024 Q1	$41.4K	Buy	+1,100	New	+$24K	﹤0.01%	4867

Other funds holding JANX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Group One Trading's JANX Position: Q1 2026 in Review

Group One Trading opened a new position in Janux Therapeutics (JANX) in Q1 2026: 592 shares worth $8.23K. The stake represents ﹤0.01% of the portfolio and ranks #6472 among its holdings. This is a return to the name: Group One Trading previously reported a position in JANX as recently as Q2 2025.

Group One Trading first reported a position in JANX in Q2 2024 and has held it in 5 quarters since. The position peaked at $351K in Q1 2025. 190 funds tracked by Wall St. Rank hold JANX as of Q1 2026.

Group One Trading held 592 shares of Janux Therapeutics worth $8.23K as of Q1 2026.
Janux Therapeutics was a new Group One Trading position in Q1 2026.
Janux Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q1 2026, its #6472 holding.
Group One Trading first reported a position in Janux Therapeutics in Q2 2024 and has held it in 5 quarters since.
Group One Trading's Janux Therapeutics position peaked at $351K in Q1 2025.
190 funds tracked by Wall St. Rank held Janux Therapeutics as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.